Nationwide competition to pilot new models of obesity support Nationwide competition to pilot new models of obesity support

Pirtobrutinib meets primary endpoint in CLL/SLL study Pirtobrutinib meets primary endpoint in CLL/SLL study

Promising results support global submissions and priority review by US FDA Promising results support global submissions and priority review by US FDA

Teva’s CGRP therapy becomes first approved option for children and adolescent Teva’s CGRP therapy becomes first approved option for children and adole...

New treatment option now available across all UK nations New treatment option now available across all UK nations

New phase of development targets chronic pain and fibromyalgia New phase of development targets chronic pain and fibromyalgia

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season

Four-year treatment slows cognitive decline with consistent safety profile Four-year treatment slows cognitive decline with consistent safety profile

MB310 study investigates safety and efficacy of precision microbiome therapy MB310 study investigates safety and efficacy of precision microbiome ther...

US$30.9 million strategic equity deal strengthens oncology platform US$30.9 million strategic equity deal strengthens oncology platform